Inhibitor Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Inhibitor Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • Inhibitor Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $5.45M, a 15.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5.45M +$722K +15.3% Dec 31, 2023 10-K 2024-03-29
Q4 2022 $4.73M -$2.91M -38.1% Dec 31, 2022 10-K 2024-03-29
Q4 2021 $7.64M +$58.4K +0.77% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $7.58M +$44K +0.58% Dec 31, 2020 10-K 2021-03-26
Q4 2019 $7.54M +$647K +9.39% Dec 31, 2019 10-K 2021-03-26
Q4 2018 $6.89M +$1.17M +20.4% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $5.72M -$422K -6.87% Dec 31, 2017 10-K 2019-03-07
Q4 2016 $6.14M +$2.55M +70.8% Dec 31, 2016 10-K 2018-02-16
Q4 2015 $3.6M +$1.43M +66.2% Dec 31, 2015 10-K 2017-02-17
Q4 2014 $2.16M +$1.41M +186% Dec 31, 2014 10-K 2016-02-01
Q4 2013 $757K -$15.3M -95.3% Dec 31, 2013 10-K 2015-02-13
Q4 2012 $16M Dec 31, 2012 10-K 2014-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.